Texas TECH University Health Sciences Center

Texas Tech University Health Sciences Center (doing business as Ttuhsc), a state-controlled institution of higher learning headquartered in Lubbock, Texas, is a prime recipient of federal research grants and a clinical-services contractor that delivers physician staffing, healthcare education, and biomedical research to the federal government, operating across five campuses serving 108 Texas counties and five health professions schools.

The institution's federal footprint is heavily concentrated in research grants and clinical physician services, with no small business set-aside posture — all awards are full-and-open. Ttuhsc competes as a prime across 90% of its awards, with a smaller subcontractor presence on research initiatives. The top customer agencies by award count are the National Institutes of Health (74 awards), Veterans Integrated Service Network 17 (54 awards, $37.1 million combined potential value), Health Resources and Services Administration (48 awards), the Bureau of Medicine and Surgery (46 awards, $1.6 million), and the National Cancer Institute (30 awards). By dollar magnitude, VISN 17 dominates the portfolio at $37.1 million across 54 awards, while the Department of Justice Bureau of Prisons holds the second-largest potential value at $4.5 million across 23 awards, reflecting Ttuhsc's established role in correctional and veteran healthcare delivery.

Representative clinical-service contracts include delivery orders with VISN 17 for pharmacy physician services ($960,960 under a $4.9 million IDC running through September 30, 2030) and onsite urology physician services (a $959,737.20 ceiling IDC through March 31, 2027). Recent orders include a $95,973.72 fixed-price delivery order for onsite urology physician services and a $24,588.87 delivery order with the Bureau of Medicine and Surgery for tuition and fees. A $34,379.41 time-and-materials purchase order from the Department of Justice Civil Rights Division covers litigative consultant services. These contracts carry no set-aside designation and are structured as delivery orders under broader indefinite-delivery vehicles, with most work performed in Texas locations (Lubbock, Dallas, Amarillo, Midland/Odessa, El Paso).

Ttuhsc's federal grant portfolio spans biomedical research across the National Institutes of Health (NIH), Department of Defense, Department of Health and Human Services agencies, and the National Science Foundation. Recent recipients grants include a $492,625 award from the National Institute of General Medical Sciences (CFDA 93.859, Biomedical Research and Research Training) for research on protein translocation quality control in the endoplasmic reticulum; a $575,904 grant from the NIH Office of the Director (CFDA 93.310, Trans-NIH Research Support) investigating protein-based transgenerational inheritance; a $999,662 award from the Health Resources and Services Administration Bureau of Health Professionals (CFDA 93.884, Primary Care Training and Enhancement) for residency training in street medicine; and a $388,229 award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855, Allergy and Infectious Diseases Research) studying endogenous retroviruses and myalgic encephalomyelitis. A $1.854 million grant from the Defense Health Agency (CFDA 12.420, Military Medical Research and Development) supports research on the role of TBX2 in prostate cancer metastasis to bone. Ttuhsc also received an $8 million congressionally directed spending award (CFDA 93.493) for healthcare facility construction and an $8 million research capacity-building cooperative agreement from the National Heart Lung and Blood Institute for rural health biomedical excellence initiatives. Grant work spans Lubbock, Amarillo, Dallas, and other Texas locations, with some research funded through collaborating prime awardees (University of Pittsburgh, University of Arizona, Cornell University, Vanderbilt University, Children's Hospital of Philadelphia, St. Jude Children's Research Hospital).

Activity has remained steady at 18–30 awards per year over the past five years; only 27 awards (combined potential value $96 thousand) face ultimate completion within the next twenty-four months, posing minimal recompete exposure. The primary parent vehicles are indefinite-delivery contracts held directly with VISN 17 for pharmacy and urology physician services, a Basic Ordering Agreement with the Bureau of Medicine and Surgery (July 15, 2025–July 14, 2035, $0.00 ceiling placeholder), and single-award IDCs for neurology physician services with VISN 17. SCI-reported invoiced activity is sparse and episodic — $593 thousand across FY2023 only, with roughly 4.3 federal FTEs delivered that year — reflecting that Ttuhsc's federal services work sits largely above or outside the SCI reporting threshold. Median government-paid hourly rates on the limited SCI-captured contracts run around $65.75/hr.

Ttuhsc operates as a child entity of the Texas Tech University System (UEI EGLKRQ5JBCZ7), headquartered in Lubbock. The institution's capability portfolio centers on clinical physician services (pharmacy, urology, neurology, correctional treatment), health professions education (tuition and training support), and federally funded biomedical research spanning cancer, neurodegenerative disease, infectious disease, cardiovascular physiology, and translational medicine. No named primary contractors or subcontractors recur across the award set; the institution functions predominantly as a prime grant recipient and clinical-services vendor to federal agencies rather than as a feeder subcontractor to larger primes.